CORZ News & Events

Mixed options sentiment in Core Scientific, Inc (CORZ), with shares up 53c, or 3.5%, near $15.69. Options volume running well above average with 93k contracts traded and calls leading puts for a put/call ratio of 0.21, compared to a typical level near 0.55. Implied volatility (IV30) dropped 2.54 near 86.24,and below the 52wk median, suggesting an expected daily move of $0.85. Put-call skew flattened, suggesting a modestly bullish tone, following an upgrade to Buy at Needham.

Mixed options sentiment in Core Scientific, Inc (CORZ), with shares up 16c, or 0.98%, near $15.99. Options volume roughly in line with average with 134k contracts traded and calls leading puts for a put/call ratio of 0.41, compared to a typical level near 0.52. Implied volatility (IV30) dropped 2.13 near 86.33,and below the 52wk median, suggesting an expected daily move of $0.87. Put-call skew steepened, indicating increased demand for downside protection, following an upgrade to Buy at Needham.

Core Scientific (CORZ) announced that it completed the initial closing of a $500M 364-day loan facility provided by Morgan Stanley (MS). "This strengthens our liquidity and enhances our financial flexibility as we execute our development and go-to-market strategy," said Adam Sullivan, CEO of Core Scientific. The facility includes an accordion feature that provides the potential to increase total commitments by up to an additional $500M, for total commitments of up to $1B, subject to customary terms and conditions. Borrowings under the facility bear interest at a rate of secured overnight financing rate plus 250 basis points.